Stocks
Intellia Therapeutics (NTLA) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -6.30 | -56.9 | -35.3 | -6.86 | -6.63 | -7.37 | |||
| Changes by years, y/y, % | -28% | +804% | -38% | -81% | -3% | -5.3% | |||
Intellia Therapeutics. P/FCF
Intellia Therapeutics. P/FCF, changes, %
Intellia Therapeutics (NTLA) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -6.88 | -6.76 | -6.28 | -5.67 | -5.72 | -7.37 | ||
| Changes by years, y/y, % | -43% | -7% | -27% | -39% | -17% | |||
| Changes by quarters, q/q, % | -26% | -2% | -7% | -10% | +1% | |||
